Rchr
J-GLOBAL ID:202101010791050714   Update date: Sep. 11, 2024

Sawamoto Kazuki

サワモト カズキ | Sawamoto Kazuki
Research field  (3): Metabolism and endocrinology ,  Molecular biology ,  Clinical pharmacy
Research keywords  (4): Clinical pharmacy ,  Bone targeting ,  Life-style related disease ,  Gene therapy
Research theme for competitive and other funds  (9):
  • 2022 - 2025 Role of Nrf2 in glucose and lipid metabolism
  • 2021 - 2022 レドックス調節因子Nrf2が肝臓における肥満特異的な代謝制御に与える影響の解明
  • 2021 - 2022 レドックス調節因子の発現制御に基づく肥満・糖尿病に対する新規予防・治療法の創出
  • 2021 - 2022 Development of new Nrf2-activating therapy for obesity and diabetes
  • 2020 - 2022 Development of a bone-targeted gene therapy using an engineered adeno-associated virus capsid
Show all
Papers (48):
  • Suratsawadee Promsuwan, Kazuki Sawamoto, Liang Xu, Mayumi Nagashimada, Naoto Nagata, Yumi Takiyama. A natural Nrf2 activator glucoraphanin improves hepatic steatosis in high-fat diet-induced obese male mice associated with AMPK activation. Diabetology International. 2023
  • Matthew Piechnik, Paige C Amendum, Kazuki Sawamoto, Molly Stapleton, Shaukat Khan, Nidhi Fnu, Victor Álvarez, Angelica Maria Herreño Pachon, Olivier Danos, Joseph T Bruder, et al. Sex Difference Leads to Differential Gene Expression Patterns and Therapeutic Efficacy in Mucopolysaccharidosis IVA Murine Model Receiving AAV8 Gene Therapy. International journal of molecular sciences. 2022. 23. 20
  • Takao Takiyama, Toshihiro Sera, Masanori Nakamura, Masato Hoshino, Kentaro Uesugi, Shin-Ichi Horike, Makiko Meguro-Horike, Ryoichi Bessho, Yuri Takiyama, Hiroya Kitsunai, et al. A maternal high-fat diet induces fetal origins of NASH-HCC in mice. Scientific reports. 2022. 12. 1. 13136-13136
  • Mayumi Nagashimada, Kazuki Sawamoto, Yinhua Ni, Hironori Kitade, Naoto Nagata, Liang Xu, Masuko Kobori, Naofumi Mukaida, Tatsuya Yamashita, Shuichi Kaneko, et al. CX3CL1-CX3CR1 signalling deficiency exacerbates obesity-induced inflammation and insulin resistance in male mice. Endocrinology. 2021. 162. 6
  • Kazuki Sawamoto, J Víctor Álvarez, Angélica María Herreño, Francisco J Otero-Espinar, Maria L Couce, Carlos J Alméciga-Díaz, Shunji Tomatsu. Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders. Current osteoporosis reports. 2020. 18. 5. 515-525
more...
MISC (52):
  • SURATSAWADEE Promsuwan, 澤本一樹, 長田直人, XU Liang, 滝山由美. グルコラファニンによる肥満・脂肪肝に対する治療効果. 糖尿病合併症. 2022. 36. Supplement-1
  • 別所 瞭一, 滝山 貴央, Promsuwan Suratsawadee, 宿田 夕季, 橘内 博哉, 澤本 一樹, 竹田 安孝, 坂上 英充, 滝山 由美. Nrf2活性化剤によるTFAM活性化とSTING抑制作用. 糖尿病. 2021. 64. Suppl.1. I-3
  • 澤本 一樹, 長田 直人, Promsuwan Suratsawadee, Xu Liang. グルコラファニンによる肥満・インスリン抵抗性に対する治療効果. 糖尿病. 2020. 63. Suppl.1. S-311
  • 澤本一樹, 長田直人, PROMSUWAN Suratsawadee, XU Liang. グルコラファニンによる肥満・インスリン抵抗性に対する治療効果. 糖尿病(Web). 2020. 63. Suppl
  • 永島田 まゆみ, 倪 銀華, 澤本 一樹, 太田 嗣人. 肥満により減弱するFractalkine-CX3CR1シグナルの回復は,インスリン抵抗性を改善する. 糖尿病. 2019. 62. Suppl.1. S-196
more...
Patents (2):
  • TREATMENT OF MUCOPOLYSACCHARIDOSIS IVA
  • AN AGENT, A DEVICE AND A BLOOD-CIRCULATION SYSTEM FOR TREATING LYSOSOMAL STORAGE DISEASES, AND A METHOD FOR TREATING LYSOSOMAL STORAGE DISEASES
Books (1):
  • Mucopolysaccharidoses update (2 volume set)
    Nova Science Publishers 2018 ISBN:9781536139860
Education (3):
  • 2011 - 2014 Kanazawa University Graduate School of Natural Science and Technology
  • 2009 - 2011 Kanazawa University Graduate School of Natural Science and Technology Division of Phamaceutical Sciences
  • 2005 - 2009 Kanazawa University Faculty of Pharmaceutical Sciences
Professional career (1):
  • Ph.D. (Kanazawa University)
Work history (4):
  • 2021/10 - 2023/03 Asahikawa Medical University
  • 2019/10 - 2021/09 Asahikawa Medical University Prevention and Therapy of Diabetes and Life style Related Diseases Laboratory Assistant Professor
  • 2014/11 - 2019/09 Nemours/Alfred l. duPont Hospital for Children Biomedical Research Post-doctoral Research Fellow
  • 2011/04 - 2014/09 University Hospital, Kanazawa University Department of Hospital Pharmacy Assistant Professor
Awards (2):
  • 2016/06 - 医療薬学フォーラム2016 優秀ポスター賞 タクロリムスの静脈内から経口投与への切り替え時における体格指数の体内動態変動に与える影響
  • 2012/07 - - -
Association Membership(s) (2):
日本分子生物学会 ,  日本薬学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page